Form 4 for EW Edwards Lifesciences
Accepted 2023-09-15 00:00:00 ET · period of report 2023-09-14 · accession 0001225208-23-008962 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-15 | 2023-09-14 | EW | Markowitz Wayne | SVP, GM, Surgical | A - Grant | $0.00 | +7,262 | 7,262 | New | $0 |
| D | 2023-09-15 | 2023-09-14 | EW | Markowitz Wayne | SVP, GM, Surgical | A - Grant | $0.00 | +19.3K | 19.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-14 | A | A | 7,262 | $0.00 | 7,262 | D | — | — | (F1) These restricted stock units were granted on September 14, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested annually in equal installments over a period of four years commencing one year after the grant date. |
| 2 | Derivative | Employee Stock Option (Right to Acquire) | 2023-09-14 | A | A | 19,256 | $0.00 | 19,256 | D | $74.02 · 2024-09-14 to 2030-09-13 | 19,256 Common Stock | (F2) These options were granted on September 14, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable annually in equal installments over a period of four years commencing one year after the grant date. |